Status:
COMPLETED
PEACE: Pediatric Antifungal Comparative Effectiveness
Lead Sponsor:
Duke University
Collaborating Sponsors:
Children's Hospital of Philadelphia
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Pediatric Invasive Candidiasis
Eligibility:
All Genders
120-18 years
Brief Summary
The overarching objective is to develop new evidence-based treatment guidelines for invasive fungal diseases in children. To accomplish that, this protocol will focus on two specific aims: 1) Compare ...
Detailed Description
This study is a multicenter, national and international, prospective observational comparative effectiveness study. The primary aim of this study is to compare the effectiveness of echinocandin versu...
Eligibility Criteria
Inclusion
- Males or females age \> 120 days and \<18 years
- Documented proven or probable case of invasive candidiasis
- Parental/guardian permission (informed consent, if required) and if appropriate, child assent (if required).
Exclusion
- 1\) Any history of prior Candida infection within the previous 35 days (These patients will not be eligible for analysis in aim 1 but will be eligible for inclusion of aim 2)
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2018
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT01869829
Start Date
January 1 2015
End Date
April 1 2018
Last Update
January 28 2022
Active Locations (35)
Enter a location and click search to find clinical trials sorted by distance.
1
Arkansas Children's Hospital
Little Rock, Arkansas, United States
2
Children's Hospital of Orange County
Orange, California, United States
3
Lucile Packard Children's Hospital at Stanford
Palo Alto, California, United States
4
Rady Children's Hospital
San Diego, California, United States